GlaxoSmithKline's Shingrix Approved in the U.S. for Prevention of Shingles in Adults Aged 50 and … Post author:Sam Post published:October 22, 2017 Post category:BioPharma Shingrix is a non-live, recombinant subunit vaccine given intramuscularly in two doses. Source: BioSpace You Might Also Like Halozyme Reports Fourth Quarter And Full Year 2016 Financial Results February 28, 2017 Bay Area's Portola Bangs Out a $150 Million Royalty Deal With February 2, 2017 Biotech Startups Salivate As Atlas Venture Launches $350 Million Fund June 28, 2017
